Advancement in leishmaniasis diagnosis and therapeutics: An update
Leishmaniasis is regarded as a neglected tropical disease by World Health Organization
(WHO) and is ranked next to malaria as the deadliest protozoan disease. The primary …
(WHO) and is ranked next to malaria as the deadliest protozoan disease. The primary …
[HTML][HTML] Bioactive peptides for anticancer therapies
Y Zhang, C Wang, W Zhang, X Li - Biomaterials Translational, 2023 - ncbi.nlm.nih.gov
Cancer is a serious concern in public health worldwide. Numerous modalities including
surgery, radiotherapy, and chemotherapy, have been used for cancer therapies in clinic …
surgery, radiotherapy, and chemotherapy, have been used for cancer therapies in clinic …
Biomedical relevance of novel anticancer peptides in the sensitive treatment of cancer
The global increase in cancer mortality and economic losses necessitates the cautious
quest for therapeutic agents with compensatory advantages over conventional therapies …
quest for therapeutic agents with compensatory advantages over conventional therapies …
Neglected zoonotic diseases: Advances in the development of cell-penetrating and antimicrobial peptides against leishmaniosis and Chagas disease
SM Robledo, S Pérez-Silanes, C Fernández-Rubio… - Pathogens, 2023 - mdpi.com
In 2020, the WHO established the road map for neglected tropical diseases 2021–2030,
which aims to control and eradicate 20 diseases, including leishmaniosis and Chagas …
which aims to control and eradicate 20 diseases, including leishmaniosis and Chagas …
Comparative study of different forms of Jellein antimicrobial peptide on Leishmania parasite
Typically, antimicrobial peptides (AMPs) are short positive charged peptides serving a key
role in innate immunity as well as antimicrobial activity. Discovering novel therapeutic …
role in innate immunity as well as antimicrobial activity. Discovering novel therapeutic …
Bioinformatics analysis for the purpose of designing a novel multi-epitope DNA vaccine against Leishmania major
Leishmaniasis is one of the main infectious diseases worldwide. In the midst of all the
different forms of the disease, Cutaneous Leishmania (CL) has the highest incidence in the …
different forms of the disease, Cutaneous Leishmania (CL) has the highest incidence in the …
Exploring membrane proteins of Leishmania major to design a new multi-epitope vaccine using immunoinformatics approach
M Rabienia, Z Roudbari, A Ghanbariasad… - European Journal of …, 2020 - Elsevier
Leishmaniasis is one of the major global endemic diseases. Among all the different forms of
the disease, cutaneous Leishmaniasis has the highest prevalence worldwide. Treatment …
the disease, cutaneous Leishmaniasis has the highest prevalence worldwide. Treatment …
Systematic review of antiprotozoal potential of antimicrobial peptides
FA Santos, GS Cruz, FA Vieira, BRS Queiroz… - Acta Tropica, 2022 - Elsevier
Protozoa is a group of microorganisms that cause neglected tropical diseases, such as
malaria, Chagas disease, and Leishmaniasis. Due to the growing demand for new …
malaria, Chagas disease, and Leishmaniasis. Due to the growing demand for new …
[HTML][HTML] Lauric acid bilayer-functionalized iron oxide nanoparticles disrupt early development of freshwater snail Biomphalaria glabrata (Say, 1818)
RV Pena, RC Machado, MB Caixeta, PS Araújo… - Acta Tropica, 2022 - Elsevier
Iron oxide nanoparticles (IONPs) have been indicated for the control of parasites and
intermediate hosts, as well as applications in several sectors of nanomedicine. However …
intermediate hosts, as well as applications in several sectors of nanomedicine. However …
Activity and Cell-Death Pathway in Leishmania infantum Induced by Sugiol: Vectorization Using Yeast Cell Wall Particles Obtained From Saccharomyces cerevisiae
DB Scariot, H Volpato, NS Fernandes… - Frontiers in Cellular …, 2019 - frontiersin.org
Visceral leishmaniasis, caused by Leishmania infantum, is a neglected tropical disease, to
which efforts in the innovation of effective and affordable treatments remain limited, despite …
which efforts in the innovation of effective and affordable treatments remain limited, despite …